tradingkey.logo

Insulet Corp

PODD
289.620USD
-3.260-1.11%
收盤 12/19, 16:00美東報價延遲15分鐘
20.37B總市值
82.66本益比TTM

Insulet Corp

289.620
-3.260-1.11%

關於 Insulet Corp 公司

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Insulet Corp簡介

公司代碼PODD
公司名稱Insulet Corp
上市日期May 15, 2007
CEOMcevoy (Ashley)
員工數量3900
證券類型Ordinary Share
年結日May 15
公司地址100 Nagog Park
城市ACTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01720-3440
電話19786007000
網址https://www.omnipod.com
公司代碼PODD
上市日期May 15, 2007
CEOMcevoy (Ashley)

Insulet Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+2.89%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-8.50%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-28.94%
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238500.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+17.43%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
3.85K
+33.25%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
3.58K
--
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.56K
-16.16%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.09K
-13.48%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+2.89%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-8.50%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-28.94%
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238500.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+17.43%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
業務USD
名稱
營收
佔比
U.S.Omnipod
453.20M
69.82%
International Omnipod
185.80M
28.62%
Drug Delivery
10.20M
1.57%
地區USD
名稱
營收
佔比
United States
463.30M
71.38%
All Other
185.80M
28.62%
業務
地區
業務USD
名稱
營收
佔比
U.S.Omnipod
453.20M
69.82%
International Omnipod
185.80M
28.62%
Drug Delivery
10.20M
1.57%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.46%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
其他
60.56%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.46%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
其他
60.56%
股東類型
持股股東
佔比
Investment Advisor
64.92%
Investment Advisor/Hedge Fund
23.48%
Hedge Fund
4.88%
Pension Fund
2.61%
Research Firm
2.52%
Sovereign Wealth Fund
1.57%
Bank and Trust
1.22%
Individual Investor
0.30%
Family Office
0.05%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1546
72.07M
102.39%
-3.66M
2025Q2
1541
72.80M
103.47%
-3.81M
2025Q1
1569
72.82M
103.50%
-3.52M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
2023Q3
1254
72.05M
103.19%
-4.06M
2023Q2
1223
73.42M
105.35%
-3.44M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
8.68M
12.33%
+38.89K
+0.45%
Jun 30, 2025
Fidelity Management & Research Company LLC
6.86M
9.74%
-271.19K
-3.80%
Jun 30, 2025
Capital Research Global Investors
4.74M
6.73%
-1.34M
-22.06%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
4.35M
6.18%
-13.40K
-0.31%
Jun 30, 2025
State Street Investment Management (US)
3.06M
4.34%
+32.74K
+1.08%
Jun 30, 2025
Baillie Gifford & Co.
2.14M
3.03%
-115.69K
-5.14%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.93M
2.74%
+58.31K
+3.12%
Jun 30, 2025
ClearBridge Investments, LLC
1.54M
2.18%
+56.63K
+3.83%
Jun 30, 2025
American Century Investment Management, Inc.
1.31M
1.86%
+157.07K
+13.63%
Jun 30, 2025
Fidelity International
1.13M
1.61%
-155.38K
-12.09%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Langar Global HealthTech ETF
7.26%
Innovator IBD Breakout Opportunities ETF
4.88%
Global X HealthTech ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.7%
iShares Health Innovation Active ETF
3%
Congress SMid Growth ETF
2.82%
iShares U.S. Medical Devices ETF
2.62%
FT Raymond James Multicap Growth Equity ETF
2.3%
Acruence Active Hedge US Equity ETF
2.27%
查看更多
Langar Global HealthTech ETF
佔比7.26%
Innovator IBD Breakout Opportunities ETF
佔比4.88%
Global X HealthTech ETF
佔比4.76%
Goldman Sachs Future Health Care Equity ETF
佔比4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比3.7%
iShares Health Innovation Active ETF
佔比3%
Congress SMid Growth ETF
佔比2.82%
iShares U.S. Medical Devices ETF
佔比2.62%
FT Raymond James Multicap Growth Equity ETF
佔比2.3%
Acruence Active Hedge US Equity ETF
佔比2.27%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Insulet Corp的前五大股東是誰?

Insulet Corp的前五大股東如下:
The Vanguard Group, Inc.
持有股份:8.68M
佔總股份比例:12.33%。
Fidelity Management & Research Company LLC
持有股份:6.86M
佔總股份比例:9.74%。
Capital Research Global Investors
持有股份:4.74M
佔總股份比例:6.73%。
BlackRock Institutional Trust Company, N.A.
持有股份:4.35M
佔總股份比例:6.18%。
State Street Investment Management (US)
持有股份:3.06M
佔總股份比例:4.34%。

Insulet Corp的前三大股東類型是什麼?

Insulet Corp 的前三大股東類型分別是:
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC
Capital Research Global Investors

有多少機構持有Insulet Corp(PODD)的股份?

截至2025Q3,共有1546家機構持有Insulet Corp的股份,合計持有的股份價值約為72.07M,占公司總股份的102.39% 。與2025Q2相比,機構持股有所增加,增幅為-1.08%。

哪個業務部門對Insulet Corp的收入貢獻最大?

在FY2025Q2,U.S.Omnipod業務部門對Insulet Corp的收入貢獻最大,創收453.20M,占總收入的69.82% 。
KeyAI